Neptune Wellness Solutions Stock Forecast, Price & News

Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

Is Neptune Wellness Solutions a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Neptune Wellness Solutions stock.
View analyst ratings for Neptune Wellness Solutions or view top-rated stocks.

How has Neptune Wellness Solutions' stock price been impacted by Coronavirus?

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEPT shares have decreased by 58.6% and is now trading at $0.5005.
View which stocks have been most impacted by COVID-19.

When is Neptune Wellness Solutions' next earnings date?

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Monday, February 21st 2022.
View our earnings forecast for Neptune Wellness Solutions.

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) posted its quarterly earnings data on Monday, November, 15th. The biotechnology company reported ($0.09) EPS for the quarter, hitting analysts' consensus estimates of ($0.09). The biotechnology company had revenue of $12.50 million for the quarter, compared to analyst estimates of $10.99 million. Neptune Wellness Solutions had a negative net margin of 344.98% and a negative trailing twelve-month return on equity of 74.86%.
View Neptune Wellness Solutions' earnings history.

What price target have analysts set for NEPT?

2 Wall Street analysts have issued 1-year price targets for Neptune Wellness Solutions' shares. Their forecasts range from $0.75 to $1.50. On average, they expect Neptune Wellness Solutions' share price to reach $1.13 in the next twelve months. This suggests a possible upside of 124.8% from the stock's current price.
View analysts' price targets for Neptune Wellness Solutions or view top-rated stocks among Wall Street analysts.

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the following people:

• Mr. James S. Hamilton, Pres, CEO & Director
• Mr. Mario Paradis, VP & CFO
• Mr. Marc Vaugeois, VP of Sales
• Mr. Michel Timperio, Pres of Cannabis Bus.
• Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

Who are some of Neptune Wellness Solutions' key competitors?

Some companies that are related to Neptune Wellness Solutions include Cogent Biosciences (COGT), Relmada Therapeutics (RLMD), BELLUS Health (BLUSF), Alpine Immune Sciences (ALPN), Theratechnologies (THTX), Aeglea BioTherapeutics (AGLE), Landos Biopharma (LABP), Millendo Therapeutics (MLND), Adicet Bio (ACET), FS Development Corp. II (FSII), Evolus (EOLS), Clene (CLNN), Homology Medicines (FIXX), Nanobiotix (NBTX) and Theratechnologies (THERF).
View all of NEPT's competitors.

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), (APHA), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and NewAge (NBEV).

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Who are Neptune Wellness Solutions' major shareholders?

Neptune Wellness Solutions' stock is owned by many different institutional and retail investors. Top institutional shareholders include Goldman Sachs Group Inc. (1.80%), Penserra Capital Management LLC (1.44%), Commonwealth Equity Services LLC (0.69%), Morgan Stanley (0.30%), Natixis (0.07%) and Citadel Advisors LLC (0.00%).

Which major investors are selling Neptune Wellness Solutions stock?

NEPT stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Wolverine Trading LLC, and Millennium Management LLC.

Which major investors are buying Neptune Wellness Solutions stock?

NEPT stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Penserra Capital Management LLC, Commonwealth Equity Services LLC, Morgan Stanley, and Natixis.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $0.50.

How much money does Neptune Wellness Solutions make?

Neptune Wellness Solutions has a market capitalization of $83.74 million and generates $35.45 million in revenue each year. The biotechnology company earns $-126.68 million in net income (profit) each year or ($1.02) on an earnings per share basis.

How many employees does Neptune Wellness Solutions have?

Neptune Wellness Solutions employs 58 workers across the globe.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

Where are Neptune Wellness Solutions' headquarters?

Neptune Wellness Solutions is headquartered at 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262, via email at [email protected], or via fax at 45-0687-2272.